Monitor upcoming quarterly filings for any updates on operational efficiency initiatives and financial performance that these retention awards are tied to. The three-year vesting period suggests management stability is a priority through at least late 2029.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $5.67entry
- T+1 · 6d ago +0.88%α −0.44% · $5.72
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Myriad Genetics granted one-time retention stock options to three named executive officers (CFO, COO, CSO) totaling 360,944 shares, vesting on the third anniversary of the grant date. The awards are designed to retain leadership as the company executes operational efficiency and financial performance initiatives.
Key Facts
- Retention Option Awards approved on November 6, 2026 for three named executive officers
- CFO Benjamin R. Wheeler received 121,379 shares subject to option
- COO Mark S. Verratti received 146,933 shares subject to option
- CSO Dale Muzzey received 92,632 shares subject to option
- Total shares subject to awards: 360,944
- Exercise price equals closing price on grant date
- Options vest on third anniversary of grant date
- Options have a 10-year term
- Awards granted under the 2026 Employee, Director and Consultant Equity Incentive Plan
Financial Impact
360,944 shares subject to stock options for three named executive officers; exercise price set at closing price on grant date
Risk Factors
- Potential dilution of approximately 0.6% of outstanding shares based on $597M market cap
- Retention awards signal possible key-person risk if executives were considering departure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-072114 |
| Document: mygn-20261106.htm | 0001628280-26-072114 |
| Document: 0001628280-26-072114-index-headers.html | 0001628280-26-072114 |
| Document: 0001628280-26-072114-index.html | 0001628280-26-072114 |
| Document: 0001628280-26-072114.txt | 0001628280-26-072114 |
Track record
16 reports on MYGN
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $5.57 Now $5.57 −0.00% settles Nov 18
- Nov 9, 20267d ago 8-K Neutral 2/10 Viewing Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
- Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
- Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers